User:Martin Panigaj: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Contact Info== | ==Contact Info== | ||
[[Image:OWWEmblem.png|thumb|right|Martin Panigaj (an artistic interpretation)]] | [[Image:OWWEmblem.png|thumb|right|Martin Panigaj (an artistic interpretation)]] | ||
| Line 6: | Line 4: | ||
*Martin Panigaj | *Martin Panigaj | ||
*FDA/CBER/OCTGT | *FDA/CBER/OCTGT | ||
* | *8800 Rockville Pike | ||
* | *Bethesda, MD, USA | ||
*[[Special:Emailuser/Martin Panigaj|Email me through OpenWetWare]] | *[[Special:Emailuser/Martin Panigaj|Email me through OpenWetWare]] | ||
==Education== | ==Education== | ||
<!--Include info about your educational background--> | <!--Include info about your educational background--> | ||
* | * 2011, PhD, Institute | ||
* | * 2002, MS, Institute | ||
==Research interests== | ==Research interests== | ||
<!-- Feel free to add brief descriptions to your research interests as well --> | <!-- Feel free to add brief descriptions to your research interests as well --> | ||
# | # Gene therapy | ||
# | # RNA biology | ||
==Publications== | ==Publications== | ||
<!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed --> | <!-- Replace the PubMed ID's ("pmid=#######") below with the PubMed ID's for your publications. You can add or remove lines as needed --> | ||
<biblio> | <biblio> | ||
#Paper1 pmid= | #Paper1 pmid=22043908 | ||
#Paper2 pmid= | #Paper2 pmid=21912705 | ||
#Paper3 pmid=21058954 | |||
# | |||
</biblio> | </biblio> | ||
Latest revision as of 21:41, 30 April 2013
Contact Info
- Martin Panigaj
- FDA/CBER/OCTGT
- 8800 Rockville Pike
- Bethesda, MD, USA
- Email me through OpenWetWare
Education
- 2011, PhD, Institute
- 2002, MS, Institute
Research interests
- Gene therapy
- RNA biology
Publications
- Dvorakova E, Prouza M, Janouskova O, Panigaj M, and Holada K. Development of monoclonal antibodies specific for glycated prion protein. J Toxicol Environ Health A. 2011;74(22-24):1469-75. DOI:10.1080/15287394.2011.618976 |
- Panigaj M, Glier H, Wildova M, and Holada K. Expression of prion protein in mouse erythroid progenitors and differentiating murine erythroleukemia cells. PLoS One. 2011;6(9):e24599. DOI:10.1371/journal.pone.0024599 |
- Panigaj M, Brouckova A, Glierova H, Dvorakova E, Simak J, Vostal JG, and Holada K. Underestimation of the expression of cellular prion protein on human red blood cells. Transfusion. 2011 May;51(5):1012-21. DOI:10.1111/j.1537-2995.2010.02924.x |
